A new study by the US Centers for Disease Control and Prevention (CDC) on Friday revealed that the Moderna COVID-19 vaccine confers better long-term protection against hospitalization than Pfizer.
CDC researchers conducted an analysis of nearly 3,689 adults who were hospitalized with severe COVID-19 from March 11 to August 15 this year, a period that precedes and includes the dominance of the Delta variant.
Overall, 12.9 percent were fully vaccinated with the Moderna vaccine, 20 percent were vaccinated with Pfizer-BioNTech, and 3.1 percent were vaccinated with Johnson & Johnson.
Over the entire period, the Moderna vaccine was 93 percent effective against hospitalization, Pfizer was 88 percent effective, and J&J was 68 percent effective.
ARR
